Combo flu-COVID mRNA vaccine shows durable immunity through 6 months in adults 50+

Key Findings

🎯 New Lipid Design Boosts Heart-Targeted mRNA Delivery 4.5x

• Researchers engineered a trace component called PEG-lipid (Pr-181-277) that dramatically improved mRNA delivery to the liver
• Replacing standard PEG-lipids with this new version increased gene expression by 4.5-fold and gene editing efficiency by 5.3-fold
• The enhancement works through a two-step mechanism: attracting albumin proteins for better liver targeting, then destabilizing cell membranes for easier cargo release

🔬 Biodegradable Alternative to PEG Reduces Vaccine Side Effects

• Scientists developed lipid nanoparticles using poly(D,L-serine) instead of PEG, which commonly triggers unwanted immune responses
• The new formulation delivered COVID spike mRNA more effectively than the clinically approved BNT162b2 vaccine in mice
• Repeated dosing produced minimal antibody responses against the delivery system, unlike PEG-based versions that cause hypersensitivity

💡 Lung-Targeted Nanoparticles Show 40x Better Gene Delivery

• A simplified delivery system using quantum dots and specific lipids achieved 40-fold higher lung-targeted gene expression than existing lung-targeting nanoparticles
• The system successfully delivered both therapeutic mRNA and anti-fibrosis drugs to treat pulmonary fibrosis in animal models
• Safety evaluations confirmed the approach reduced toxic side effects while maintaining strong therapeutic activity

🧪 New Chemistry Platform Enables Rapid Screening of 500 Gene Editing Carriers

• Researchers developed a plug-and-play method to quickly assemble biodegradable lipid carriers from simple chemical building blocks
• After screening 500 different formulations with machine learning assistance, they identified lead candidates for delivering gene editing tools
• The best performers showed superior gene editing activity compared to industry benchmark nanoparticles in wild-type and genetically modified mice

🎯 Antibody-Targeted Nanoparticles Deliver Cancer-Fighting mRNA to Specific Cells

• Cell membrane vesicles engineered with CD6 proteins successfully targeted CD166-overexpressing tumor cells
• The targeted delivery system increased IL-24 cancer-fighting protein expression and activated cell death pathways in colorectal and skin cancer models
• Treatment promoted immune cell infiltration and shifted the tumor environment toward a more inflammatory, anti-cancer state

🔬 Circular RNA Vaccines Provide Long-Term Protection Against Mpox

• Two circular RNA vaccines encoding different mpox virus proteins provided complete protection against lethal viral challenge in mice for at least 40 weeks
• The vaccines worked at low doses (2-4 μg) and induced both antibody and cellular immune responses
• Circular RNA's resistance to degradation enabled prolonged antigen expression compared to traditional linear mRNA